Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $181.32M+41.7% | $127.93M+122% | $57.62M+12.4% | $51.24M+58.1% | $32.42M+144% | ||
| $33.51M+4.9% | $31.95M+3.2% | $30.96M+3.7% | $29.85M+5.5% | $28.3M+1.9% | ||
| $305.84M-10.0% | $339.99M+3.7% | $327.76M-6.6% | $351.08M+14.4% | $306.92M+4.0% | ||
| $65.08M-7.1% | $70.06M+10.4% | $63.45M-6.8% | $68.09M+21.8% | $55.89M+7.6% | ||
| -$116.18M-3.5% | -$112.26M-35.5% | -$82.87M-2.2% | -$81.12M-32.9% | -$61.03M+3.1% | ||
| $2.83B+5.0% | $2.69B+1,485% | $170M— | —— | —— | ||
| —— | —— | —— | -$234.4M-2.9% | -$227.8M-7.6% | ||
| $136.01M-30.1% | $194.52M+21.5% | $160.06M+370% | $34.05M+103% | $16.78M-13.1% | ||
| $240.77M-10.8% | $269.93M+2.1% | $264.31M-6.6% | $282.99M+12.7% | $251.03M+3.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.